Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation

A senescence-associated secretory phenotype (SASP) and a mild inflammatory response characteristic of senescent cells (inflammaging) form the conditions for the development of cardiovascular diseases: atherosclerosis, coronary heart disease, and myocardial infarction. The purpose of the review is to...

Full description

Bibliographic Details
Published in:	Cells
Main Authors:	Vladimir Khavinson, Natalia Linkova, Anastasiia Dyatlova, Raisa Kantemirova, Kirill Kozlov
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	SASP inflammaging peptides cardiovascular pathology aging
Online Access:	https://www.mdpi.com/2073-4409/12/1/106

Similar Items

Inflammaging, an Imbalanced Immune Response That Needs to Be Restored for Cancer Prevention and Treatment in the Elderly
by: Juana Serrano-López, et al.
Published: (2021-09-01)

A narrative review on inflammaging and late-onset hypogonadism
by: Dong Xing, et al.
Published: (2024-01-01)

Centenarians Alleviate Inflammaging by Changing the Ratio and Secretory Phenotypes of T Helper 17 and Regulatory T Cells
by: Lixing Zhou, et al.
Published: (2022-06-01)

Immunosenescence, Inflammaging, and Lung Senescence in Asthma in the Elderly
by: Tomoyuki Soma, et al.
Published: (2022-10-01)

Recent advances in senescence-associated secretory phenotype and osteoporosis
by: Haonan Fan, et al.
Published: (2024-02-01)

Colchicine Protects against Ethanol-Induced Senescence and Senescence-Associated Secretory Phenotype in Endothelial Cells
by: Huakang Zhou, et al.
Published: (2023-04-01)

Interconnections between Inflammageing and Immunosenescence during Ageing
by: Thibault Teissier, et al.
Published: (2022-01-01)

Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes
by: Jiaqiang Xiong, et al.
Published: (2024-09-01)

IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma
by: Lorenzo Homann, et al.
Published: (2022-04-01)

Cardiovascular Inflammaging: Mechanisms and Translational Aspects
by: Maria Luisa Barcena, et al.
Published: (2022-03-01)

Senescent cell-derived extracellular vesicles as potential mediators of innate immunosenescence and inflammaging
by: Shaun Hanley, et al.
Published: (2024-03-01)

Mechanisms and therapeutic strategies for senescence-associated secretory phenotype in the intervertebral disc degeneration microenvironment
by: Yang Liu, et al.
Published: (2024-03-01)

Inflammaging and Senescence-Driven Extracellular Matrix Remodeling in Age-Associated Cardiovascular Disease
by: Ewelina Młynarska, et al.
Published: (2025-10-01)

Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature
by: Shangkun Zhao, et al.
Published: (2024-01-01)

Branched‐Chain Amino Acid Accumulation Fuels the Senescence‐Associated Secretory Phenotype
by: Yaosi Liang, et al.
Published: (2024-01-01)

Peptides: Prospects for Use in the Treatment of COVID-19
by: Vladimir Khavinson, et al.
Published: (2020-09-01)

Telomere attrition and inflammation: the chicken and the egg story
by: J. P. Shirley Niveta, et al.
Published: (2022-08-01)

Editorial: Cardiovascular inflammaging: basic and translational aspects
by: Maria Luisa Barcena, et al.
Published: (2024-03-01)

Inflammaging: Expansion of Molecular Phenotype and Role in Age-Associated Female Infertility
by: Dmitry Ivanov, et al.
Published: (2024-09-01)

IGFBP7 is a key component of the senescence-associated secretory phenotype (SASP) that induces senescence in healthy cells by modulating the insulin, IGF, and activin A pathways
by: Yesuf Siraj, et al.
Published: (2024-11-01)

Senescence-associated secretory phenotype in lung cancer: remodeling the tumor microenvironment for metastasis and immune suppression
by: Chen Chen, et al.
Published: (2025-05-01)

The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases
by: Lorenzo Cuollo, et al.
Published: (2020-12-01)

Alpha synuclein and inflammaging
by: Geneviève L. Putnam, et al.
Published: (2025-01-01)

Editorial: Inflammaging and immunosenescence: role in aging-associated cardiovascular diseases
by: Tlili Barhoumi, et al.
Published: (2025-05-01)

Biomarkers of inflammaging in geriatric syndromes
by: S. O. Lukyanova, et al.
Published: (2025-06-01)

Neurovascular Inflammaging in Health and Disease
by: Ádám Mészáros, et al.
Published: (2020-07-01)

Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors
by: Chuandong Hou, et al.
Published: (2024-01-01)

Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications
by: Ludmila Müller, et al.
Published: (2024-06-01)

Arsenite exposure induces premature senescence and senescence-associated secretory phenotype (SASP) in human hepatocyte-derived cell line Huh-7
by: Kazuyuki Okamura, et al.
Published: (2024-12-01)

Action Mechanisms of Small Extracellular Vesicles in Inflammaging
by: Rocío Mato-Basalo, et al.
Published: (2022-04-01)

Role of inflammaging in the development of chronic heart failure and osteoporosis: A literature review
by: Vera N. Larina, et al.
Published: (2024-11-01)

JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression
by: Torben Redmer, et al.
Published: (2024-05-01)

Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration
by: Smathorn Thakolwiboon, et al.
Published: (2023-10-01)

Age-related obesity and inflammaging in cats
by: Miki Kobayashi, et al.
Published: (2025-10-01)

Fasting and calorie restriction modulate age‐associated immunosenescence and inflammaging
by: Anteneh Mehari Tizazu
Published: (2024-08-01)

New insights into healthy ageing, inflammageing and frailty using metabolomics
by: Genna Abdullah, et al.
Published: (2024-07-01)

Anti-Aging Potential of Platelet Rich Plasma (PRP): Evidence from Osteoarthritis (OA) and Applications in Senescence and Inflammaging
by: James Vun, et al.
Published: (2023-08-01)

Senotherapeutic Peptide 14 Suppresses Th1 and M1 Human T Cell and Monocyte Subsets In Vitro
by: Thuany Alencar-Silva, et al.
Published: (2024-05-01)

Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics
by: Yo Oguma, et al.
Published: (2023-09-01)

Natural Modulators of Key Signaling Pathways in Skin Inflammageing
by: Ren Q, et al.
Published: (2024-12-01)